Nonobstructive Coronary Lesions and Ventricular Dysfunction

Many patients arrive to the cath lab for a diagnostic coronary angiography after an echo showing severe ventricular dysfunction, even in asymptomatic patients. In many occasions, their coronary arteries are normal, and in many others, we find coronary disease that is not enough to warrant such severe ventricular dysfunction.

Double Kissing Crush vs. Provisional Stenting

Patients with heart failure are frequently divided according to aetiology in ischemic and nonischemic. However, such binary classification combines patients with normal coronary arteries and patients with nonobstructive disease who might have a different prognosis.

This study divided patients with ventricular dysfunction into those with normal coronary arteries, nonobstructive disease, and obstructive disease.

The primary endpoint was a composite of cardiovascular death, nonfatal infarction, nonfatal stroke, and heart failure hospitalization.


Read also: The First Antidote Against Ticagrelor Is a Rapid-Acting, Extended Effect Agent in Preliminary Results.


Of 12,814 patients, 2656 (20.7%) had normal coronary arteries, 2254 (17.6%) had nonobstructive disease, and 7904 (61.7%) had obstructive disease.

The risk of the primary endpoint was significantly higher in the nonobstructive group (hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.04 to 1.32; p = 0.01) compared with the group with normal coronary arteries.


Read also: Patients: What They Really Want to Know about Their Disease.


Nonobstructive coronary artery disease was associated with an increase in cardiovascular death (HR: 1.82; 95% CI: 1.27 to 2.62; p = 0.001) and all-cause mortality (HR: 1.18; 95% CI: 1.05 to 1.33; p = 0.005). Still, there were no differences as regards acute myocardial infarction, stroke, or heart failure hospitalization.

Conclusion

Among patients with left ventricular dysfunction, the presence of nonobstructive coronary artery disease was independently associated with an increase in composite events and mortality.

Original title: Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.

Reference: Juarez R. Braga et al. J Am Coll Cardiol HF 2019, article in press.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...